Gee‐Hong Kuo

1.2k citations

46 papers · 1.0k indexed · h-index 22

Organic Chemistry top 5%
Molecular Biology
Endocrinology, Diabetes and Metabolism top 10%
Surgery
Computational Theory and Mathematics top 5%

Co-authors: Keith T. Demarest William V. Murray Harry H. Wasserman Thomas A. Rano Patricia D. PeltonJun XuCatherine Prouty Linda K. Jolliffe
Topics: Peroxisome Proliferator-Activated Receptors (8 papers)Receptor Mechanisms and Signaling (7 papers)Metabolism, Diabetes, and Cancer (6 papers)
Cited by: Organic Chemistry Toxicology Endocrinology, Diabetes and Metabolism
Journals: Analytical Biochemistry Journal of Medicinal Chemistry Journal of Pharmacology and Experimental Therapeutics
Partner nations: United States Belgium Norway

In The Last Decade

Gee‐Hong Kuo

43 papers receiving 975 citations

Peers

Countries citing papers authored by Gee‐Hong Kuo

Since Specialization

Citations

This map shows the geographic impact of Gee‐Hong Kuo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gee‐Hong Kuo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gee‐Hong Kuo more than expected).

Fields of papers citing papers by Gee‐Hong Kuo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gee‐Hong Kuo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gee‐Hong Kuo. The network helps show where Gee‐Hong Kuo may publish in the future.

Co-authorship network of co-authors of Gee‐Hong Kuo

This figure shows the co-authorship network connecting the top 25 collaborators of Gee‐Hong Kuo. A scholar is included among the top collaborators of Gee‐Hong Kuo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gee‐Hong Kuo. Gee‐Hong Kuo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	5,5-Difluoro- and 5-Fluoro-5-methyl-hexose-based C-Glucosides as potent and orally bioavailable SGLT1 and SGLT2 dual inhibitors 2020 ·Bioorganic & Medicinal Chemistry Letters ·Guozhang Xu,Fuyong Du,Gee‐Hong Kuo,June Xu,Yin Liang,Keith T. Demarest,Michael D. Gaul	10
2	Synthesis and biological evaluation of benzocyclobutane-C-glycosides as potent and orally active SGLT1/SGLT2 dual inhibitors 2018 ·Bioorganic & Medicinal Chemistry Letters ·Gee‐Hong Kuo,Micheal D. Gaul,Yin Liang,June Xu,Fuyong Du,Pamela J. Hornby,Guozhang Xu,Jenson Qi,Nathaniel Wallace,Seung‐Hun Lee,Eugene B. Grant,William V. Murray,Keith T. Demarest	29
3	Potent Sodium/Glucose Cotransporter SGLT1/2 Dual Inhibition Improves Glycemic Control Without Marked Gastrointestinal Adaptation or Colonic Microbiota Changes in Rodents 2018 ·Journal of Pharmacology and Experimental Therapeutics ·Fuyong Du,Simon A. Hinke,Cassandre Cavanaugh,David Polidori,(unknown),Thomas Kirchner,Matthew Jennis,Wensheng Lang,Gee‐Hong Kuo,Micheal D. Gaul,James M. Lenhard,Keith T. Demarest,Nadim J. Ajami,Yin Liang,Pamela J. Hornby	25
4	Novel LC/MS/MS and High-Throughput Mass Spectrometric Assays for Monoacylglycerol Acyltransferase Inhibitors 2017 ·SLAS DISCOVERY ·Jenson Qi,John A. Masucci,Wensheng Lang,Margery A. Connelly,Gary W. Caldwell,Ioanna P. Petrounia,(unknown),Alexander N. Barnakov,Geoffrey T. Struble,(unknown),(unknown),Gee‐Hong Kuo,Michael D. Gaul,Alessandro Pocai,Seung‐Hun Lee	0
5	Metabolic tracing of monoacylglycerol acyltransferase-2 activity in vitro and in vivo 2016 ·Analytical Biochemistry ·Jenson Qi,Wensheng Lang,Margery A. Connelly,Fuyong Du,Yin Liang,Gary W. Caldwell,(unknown),Michael K. Hansen,Gee‐Hong Kuo,Michael D. Gaul,Alessandro Pocai,(unknown)	1
6	4-Bicyclic heteroaryl-piperidine derivatives as potent, orally bioavailable stearoyl-CoA desaturase-1 (SCD1) inhibitors: Part 2. Pyridazine-based analogs 2014 ·Bioorganic & Medicinal Chemistry Letters ·Shyh‐Ming Yang,Yuting Tang,Thomas A. Rano,(unknown),Gee‐Hong Kuo,Michael D. Gaul,Yaxin Li,(unknown),Wensheng Lang,James G. Conway,Yin Liang,James M. Lenhard,Keith T. Demarest,William V. Murray	6
7	4-Bicyclic heteroaryl-piperidine derivatives as potent, orally bioavailable Stearoyl-CoA desaturase-1 (SCD1) inhibitors. Part 1: Urea-based analogs 2013 ·Bioorganic & Medicinal Chemistry Letters ·Shyh‐Ming Yang,Yuting Tang,Rui Zhang,(unknown),Gee‐Hong Kuo,Michael D. Gaul,Yaxin Li,(unknown),James G. Conway,Yin Liang,James M. Lenhard,Keith T. Demarest,William V. Murray	5
8	Optimization of a pyrazole hit from FBDD into a novel series of indazoles as ketohexokinase inhibitors 2011 ·Bioorganic & Medicinal Chemistry Letters ·Xuqing Zhang,(unknown),Gee‐Hong Kuo,(unknown),Alan C. Gibbs,M.C. Abad,Weimei Sun,Lawrence C. Kuo,Zhihua Sui	20
9	Torcetrapib Produces Endothelial Dysfunction Independent of Cholesteryl Ester Transfer Protein Inhibition 2010 ·Journal of Cardiovascular Pharmacology ·Margery A. Connelly,Tom J. Parry,Edward C. Giardino,Zhihong Huang,Wai-man Cheung,Cailin Chen,Frank Cools,(unknown),David J. Gallacher,Gee‐Hong Kuo,Troy C. Sarich,Keith T. Demarest,Bruce P. Damiano	30
10	Synthesis and discovery of 2,3-dihydro-3,8-diphenylbenzo[1,4]oxazines as a novel class of potent cholesteryl ester transfer protein inhibitors 2010 ·Bioorganic & Medicinal Chemistry Letters ·Aihua Wang,Catherine Prouty,Patricia D. Pelton,(unknown),Keith T. Demarest,William V. Murray,Gee‐Hong Kuo	34
11	Discovery and SAR of para-alkylthiophenoxyacetic acids as potent and selective PPARδ agonists 2009 ·Bioorganic & Medicinal Chemistry Letters ·Rui Zhang,(unknown),Aihua Wang,Ellen Sieber-McMaster,Xun Li,Ronald K. Russell,Patricia D. Pelton,Jun Xu,Peifen Zhu,Lubing Zhou,Keith T. Demarest,William V. Murray,Gee‐Hong Kuo	8
12	Synthesis and structure–activity relationships of thiadiazole-derivatives as potent and orally active peroxisome proliferator-activated receptors α/δ dual agonists 2007 ·Bioorganic & Medicinal Chemistry ·Lan Shen,Yan Zhang,Aihua Wang,Ellen Sieber-McMaster,Xiaoli Chen,Patricia D. Pelton,June Xu,Maria Yang,Peifen Zhu,Lubing Zhou,Michael Reuman,(unknown),Ronald K. Russell,Alan C. Gibbs,(unknown),Keith T. Demarest,William V. Murray,Gee‐Hong Kuo	21
13	Discovery of para-alkylthiophenoxyacetic acids as a novel series of potent and selective PPARδ agonists 2007 ·Bioorganic & Medicinal Chemistry Letters ·Rui Zhang,Aihua Wang,(unknown),Patricia D. Pelton,Jun Xu,Peifen Zhu,Lubing Zhou,Keith T. Demarest,William V. Murray,Gee‐Hong Kuo	23
14	Hepatic metabolism of two α-1A-adrenergic receptor antagonists, phthalimide-phenylpiperazine analogs (RWJ-69205 and RWJ-69471), in the rat, dog and human 2006 ·European Journal of Drug Metabolism and Pharmacokinetics ·W. N. Wu,L. A. McKown,Gee‐Hong Kuo	2
15	Metabolism of the new α-1A-adrenergic receptor antagonist, phthalimide-phenylpiperazine analog (RWJ-69442), in rat, dog and human hepatic S9 fractions, and in rats 2005 ·European Journal of Drug Metabolism and Pharmacokinetics ·W. N. Wu,L. A. McKown,Gee‐Hong Kuo	3
16	Design, synthesis, and biological evaluation of novel 7-azaindolyl-heteroaryl-maleimides as potent and selective glycogen synthase kinase-3β (GSK-3β) inhibitors 2004 ·Bioorganic & Medicinal Chemistry ·David J. O’Neill,Lan Shen,Catherine Prouty,Barbara R. Conway,Lori Westover,Jun Xu,Han‐Cheng Zhang,Bruce E. Maryanoff,William V. Murray,Keith T. Demarest,Gee‐Hong Kuo	41
17	3-(7-Azaindolyl)-4-arylmaleimides as potent, selective inhibitors of glycogen synthase kinase-3 2004 ·Bioorganic & Medicinal Chemistry Letters ·Han‐Cheng Zhang,Hong Ye,Barbara R. Conway,Claudia K. Derian,Marylyn M. Addo,Gee‐Hong Kuo,Leonard R. Hecker,(unknown),Jian Li,Lori Westover,Jun Xu,Richard Look,Keith T. Demarest,Patricia Andrade‐Gordon,Bruce P. Damiano,Bruce E. Maryanoff	57
18	Arylpiperazine substituted heterocycles as Selective α1a adrenergic antagonists 2002 ·Bioorganic & Medicinal Chemistry Letters ·Haripada Khatuya,R. H. Hutchings,Gee‐Hong Kuo,Virginia Pulito,Linda K. Jolliffe,Xiaobing Li,William V. Murray	11
19	Design, synthesis and biological evaluation of pyridine-phenylpiperazines: A novel series of potent and selective α1a-adrenergic receptor antagonist 2000 ·Bioorganic & Medicinal Chemistry ·Gee‐Hong Kuo,Catherine Prouty,William V. Murray,Virginia Pulito,Linda K. Jolliffe,Peter Cheung,(unknown),(unknown),(unknown)	17
20	Novel cAMP PDE III inhibitors: imidazo[4,5-b]pyridin-2(3H)-ones and thiazolo[4,5-b]pyridin-2(3H)-ones and their analogs 1994 ·Journal of Medicinal Chemistry ·B. N. Singh,Edward R. Bacon,Shaughnessy Robinson,(unknown),George Y. Lesher,Virendra Kumar,(unknown),Michael Reuman,Gee‐Hong Kuo	23

About Gee‐Hong Kuo

Gee‐Hong Kuo is a scholar working on Toxicology, Biochemistry and Pharmacology, having authored 46 papers that have together received 1.0k indexed citations. Recurring topics across this work include Peroxisome Proliferator-Activated Receptors (8 papers), Receptor Mechanisms and Signaling (7 papers) and Metabolism, Diabetes, and Cancer (6 papers). The work is most often cited by research in Organic Chemistry (540 citations), Toxicology (39 citations) and Endocrinology, Diabetes and Metabolism (134 citations). Gee‐Hong Kuo has collaborated with scholars based in United States, Belgium and Norway. Frequent co-authors include Keith T. Demarest, William V. Murray, Harry H. Wasserman, Thomas A. Rano, Patricia D. Pelton, Jun Xu, Catherine Prouty, Linda K. Jolliffe, Ellen Sieber-McMaster and Maria Yang. Their work appears in journals such as Analytical Biochemistry, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact